Increased programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2) expression levels on HRSCs constitute a vital mechanism of immune evasion in cHL. Here, PDCD1LG2 is linked to classic Hodgkin lymphoma.